I think in the author&#x27;s ideal world, the lowered profit for Gilead would mean they aren&#x27;t rushing to provide Sovaldi a multi-billion dollar profit either.  So the price drops well below $11 billion, and you get a solid profit margin without gouging people that need the drug.